PSMA Conundrums & Triplet vs Doublet | PROSPECT Podcast part 1

Highlights from a GU Cast Live Event! Dr Kim Chi (Medical Oncologist, Vancouver) and Dr Carmen Mir (Urologist, Valencia) joined the PROSPECT meeting in Melbourne to discuss high-risk prostate cancer and mHSPC, along with many experts from around Australia. On the eve of the meeting over dinner, Declan Murphy led a GU Cast-themed panel discussion on five hot topics in prostate cancer, featuring snippets from GU Cast over the past few months. Part 1 today features PSMA conundrums and triplet vs doublet therapy.

This is a Themed Podcast supported by our Gold Partners, Johnson & Johnson, who also support the PROSPECT meeting.

 

Also available as an audio-only podcast, just search GU Cast wherever you get your podcasts, or play directly below

Previous
Previous

The MSKCC PLND RCT | Please explain!!!

Next
Next

Treatment intensification in mHSPC | The Who, When, and How? Live webinar replay